- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04136678
The Effect of Treadmill Back Walking Training on Balance and Function in Cerebral Palsy (CP)
The aim of this study was to investigate the effect of treadmill back walking training on balance and function in cerebral palsy.
In our study, scientific data will be prepared by clinical measurement tools in order to determine whether there is balance and walking effect of easy and practicable treadmill back walking training in the clinical setting in Cerebral Palsy.
Studie Overzicht
Gedetailleerde beschrijving
Measurements will be made at baseline and after each 8 weeks of physiotherapy program, the results will be compared.
30 minutes of the physiotherapy session, which we will apply for 2 days and 45 minutes; in the prone, supine, crawling and above knee positions; They will take physiotherapy training based on neurodevelopmental therapy consisting of fine motor activities, standing up, weight transfer, stretching, strengthening and balance exercises with mat activities such as rotation, weight transfer, sitting.
- Term: After the first measurements, the participants will take 8 minutes, 2 days a week, the regular physiotherapy session based on 30 minutes Neurodevelopmental Therapy as described above, as well as 15 minutes conventional walking training, then the measurements will be repeated.
- Term: After the second measurements, the participants will take 8 weeks, 2 days a week, the regular physiotherapy session based on 30 minutes of Neurodevelopmental Therapy as described above, as well as 15 minutes of treadmill back walking training, then the measurements will be repeated.
- Term: After the third measurements, the participants will take 8 weeks, 2 days a week, the regular physiotherapy session based on the 30 minute Neurodevelopmental Therapy described above, as well as the 15-minute treadmill walking forward training, then the measurements will be repeated.
Statistical method (s) to be used: In the analysis of the results to be obtained in our study, SPS statistics 22.0 version of SPSS statistical package will be used under the Windows operating system Statistical Package for Social Sciences (SPSS). Descriptive statistical information will be shown as arithmetic mean ± Standard Deviation (x statistical ± Ss) or percentage (%) and the level of statistical significance will be considered as p≤0.05.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
İ̇stanbul, Kalkoen, (535) 020-6774
- Halkalı, Yükselen Başarı, Abı Hayat, Altın, Özlem and Çocuklarla Elele Education and Rehabilitation Center.
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Those who are between 6 and 18 years old and have a medical report on the diagnosis of cerebral palsy,
- Classes classified as Level I and II by Gross Motor Function Classification System (GMFCS),
- Lower extremity spasticity classified as 1st and 2nd degree according to Modified Modified Ashworth Scale,
- To understand and apply verbal commands and instructions.
- Volunteer to participate in the study,
- Read and approve the informed consent form.
Exclusion Criteria:
- Active epileptic seizures
- Those with visual or auditory defects,
- Those with fixed deformities in the lower extremities,
- Patients with a history of surgery in the lower extremity musculoskeletal system in the last 6 months
- Injection of Botulinum Toxin (BOTOX) for lower extremity within the last 6 months Spasticity drug users,
- Those with mental and cognitive problems will be excluded from the study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: treadmill back walking training
15 minutes conventional walking training, 15 minutes of treadmill back walking training, 15-minute treadmill forward walking training
|
15 minutes of conventional walking training 15 minutes of treadmill backward walking training 15 minutes of treadmil forward walking training
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
The Pediatric Balance Scale
Tijdsspanne: 8 weeks
|
It can be considered as a simple, valid scale for studying functional balance capacity in children with spastic SP (Yi 2012).
Pediatric Berg Balance Scale (PBBS) will be used to evaluate the functional balance of daily living activities.
Higher scores mean a better outcome.
|
8 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
The Rivermead Visual Gait Assessment
Tijdsspanne: 8 weeks
|
RVGA allows rapid assessment and documentation of gait disturbances without equipment in the clinic and demonstration of clinical changes (Lord, et al. 1998).
Visual parameters of walking in our study will be evaluated by The Rivermead Visual Gait Assessment (RVGA).
Higher scores mean a worse outcome.
|
8 weeks
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: H D Doğan, Pt, Istanbul Medipol University Hospital
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- halisdogan
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .